Tag - breast cancer

Developments

OncoSec presents interim Phase 2 data in metastatic triple negative breast cancer

OncoSec Medical (NASDAQ:ONCS) presented interim results from KEYNOTE-890, an ongoing Phase 2 study of its TAVO drug candidate in combination with KEYTRUDA in patients with metastatic, chemotherapy-refractory triple...

December 13, 2019

Developments

BriaCell to present clinical findings at San Antonio Breast Cancer Symposium

BriaCell Therapeutics (TSXV:BCT; OTCQB:BCTXF) will highlight its lead product candidate, Bria-IMT, in two poster sessions during the 2019 San Antonio Breast Cancer Symposium. The Dec. 12 poster will summarize the data...

November 12, 2019

Developments

BriaCell doses first patient in advanced breast cancer combination study

BriaCell Therapeutics (TSXV:BCT; OTCQB:BCTXF)initiated dosing in a Phase 1/2a clinical study of its lead product candidate, Bria-IMT, in combination with Incyte’s INCMGA00012 and epacadostat in patients with advanced...

October 7, 2019

Feature

Pivot Pharma seeks financing to develop drugs for women’s cancers

By Len Zehr Upstart Pivot Pharmaceuticals (OTCQB:PVOTF), which was launched in the fourth quarter last year, is in talks with investors to raise up to $8-million in 2016 to initiate proof-of-concept studies for one of...

March 29, 2016

Tag - breast cancer

OncoSec presents interim Phase 2 data in metastatic triple negative breast cancer

BriaCell to present clinical findings at San Antonio Breast Cancer Symposium

BriaCell doses first patient in advanced breast cancer combination study

Pivot Pharma seeks financing to develop drugs for women’s cancers

General

More